With $97M raise, Thyme Care becomes unicorn, plans to scale AI-powered cancer care navigation — TFN
Thyme Care has raised $97 million in its Series D round, pushing its valuation beyond $1 billion.| Tech Funding News
London-headquartered early-stage healthtech investor Spex Capital has announced the first €30 million commitment to its new €100 million…| Tech Funding News
Thyme Care has raised $97 million in its Series D round, pushing its valuation beyond $1 billion.| Tech Funding News
